GENinCode (LON:GENI) Shares Up 14.3% – Here’s Why

GENinCode Plc (LON:GENIGet Free Report)’s stock price traded up 14.3% on Wednesday . The company traded as high as GBX 4.80 ($0.06) and last traded at GBX 4.80 ($0.06). 316,261 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 1,354,248 shares. The stock had previously closed at GBX 4.20 ($0.05).

GENinCode Trading Up 3.6 %

The company has a current ratio of 2.60, a quick ratio of 15.89 and a debt-to-equity ratio of 9.27. The business’s 50-day simple moving average is GBX 3.86 and its two-hundred day simple moving average is GBX 5.06. The company has a market capitalization of £7.61 million, a PE ratio of -86.00 and a beta of 0.66.

GENinCode Company Profile

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Featured Articles

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.